SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-19-193205
Filing Date
2019-07-12
Accepted
2019-07-12 16:05:56
Documents
4
Period of Report
2019-07-11
Items
Item 4.01: Changes in Registrant's Certifying Accountant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d41118d8k.htm 8-K 28528
2 EX-16.1 d41118dex161.htm EX-16.1 1845
3 GRAPHIC g41118img01.jpg GRAPHIC 16192
4 GRAPHIC g41118img02.jpg GRAPHIC 15017
  Complete submission text file 0001193125-19-193205.txt   75036
Mailing Address 19900 MACARTHUR BLVD. SUITE 550 IRVINE CA 92612
Business Address 19900 MACARTHUR BLVD. SUITE 550 IRVINE CA 92612 949-238-8090
Novus Therapeutics, Inc. (Filer) CIK: 0001404281 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36620 | Film No.: 19953122
SIC: 2834 Pharmaceutical Preparations